Boom in unapproved medicinal cannabis products worries Australian experts

Some patients are taking cannabis for conditions where there is little evidence it is effective, GPs and researchers say

• Get our free news app, morning email briefing or daily news podcast

Prescriptions for unapproved medicinal cannabis products in Australia have quadrupled since 2019, with half issued for adults aged 24 and under.

Researchers and GPs' representatives have questioned whether the boom has led to patients taking cannabis for conditions where there is little evidence it is effective, given large gaps in the data and the role of cannabis manufacturers in promoting their product to practitioners.

Sign up to receive an email with the top stories from Guardian Australia every morning